Physician profile
George B Cavanagh
NPI 1477554293
$2,429.11
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,582 · 2020: $320 · 2021: $16.20 · 2022: $511.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $320.18 | 2019-2022 | |
| Astellas Pharma US INC | $305.16 | 2019 | |
| Novo Nordisk INC | $236.67 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $187.75 | 2019-2020 | |
| Glaxosmithkline, LLC. | $173.52 | 2019-2022 | |
| Pfizer INC. | $147.26 | 2019-2020 | |
| Amgen INC. | $124.38 | 2019 | |
| Abbvie INC. | $122.20 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $118.84 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.43 | 2019 | |
| Amarin Pharma, INC. | $103.71 | 2019-2020 | |
| Lilly USA, LLC | $95.32 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $59.21 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.11 | 2019-2020 | |
| Allergan, INC. | $49.34 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $49.15 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $38.48 | 2019-2020 | |
| Boston Scientific Corporation | $35.34 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $22.66 | 2022 | |
| Abbott Laboratories | $20.45 | 2022 | |
| Sanofi Pasteur INC. | $18.36 | 2020 | |
| Shire North American Group INC | $17.11 | 2019 | |
| Medtronic Vascular, INC. | $14.98 | 2019 | |
| Eisai INC. | $12.50 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Cavanagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.